3 patient evaluations for Natalizumab taken for the purpose of 'General health'
11 members have decided to share their profiles only with other members of PatientsLikeMe.
Sort by:
Most recent
Feb 27, 2017 (Started Jan 15, 2011)
-
EffectivenessMajor (for General health)
-
EffectivenessNone (for Improve mobility)
-
EffectivenessMajor (for multiple sclerosis)
-
Side effectsModerate (slower gait, bowel problems)
-
AdherenceNever taken as prescribed
-
BurdenNot at all hard to take
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Jan 14, 2017 (Started Jan 15, 2011)
-
EffectivenessMajor (for multiple sclerosis)
-
Side effectsSevere (slower gait, bowel problems)
-
AdherenceSometimes
-
BurdenSomewhat hard to take
Dosage:
300 mg/15 mL
every 4 weeks
- 0 helpful marks
Sep 2, 2009 (Started Nov 28, 2008)
-
EffectivenessMajor (for General health)
-
Side effectsNone
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg/15 mL
Monthly
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
$200+ monthly
Aug 21, 2009 (Started Nov 28, 2008)
-
EffectivenessMajor (for General health)
-
Side effectsNone
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg/15 mL
Monthly
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
$200+ monthly
- 2 helpful marks
Sep 25, 2008 (Started Dec 31, 2007)
-
EffectivenessMajor (for General health)
-
Side effectsMild (headaches)
-
AdherenceAlways
-
BurdenNot at all hard to take
Dosage:
300 mg/15 mL
Monthly
Advice & Tips:
Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Phasellus faucibus turpis sed mi maximus mattis.
Cost:
< $25 monthly
Side effects:
headaches, headaches
- 0 helpful marks
Last updated:
Showing 3 of 3 patient evaluations for Natalizumab